8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T75150 | GIP/GLP-1 dual receptor agonist-1 | ||
GIP/GLP-1 dual receptor agonist-1 (compound 4), a receptor agonist for both GIP and GLP-1, shows potential for the research of metabolic disorders and fatty liver diseases, such as nonalcoholic steatohepatitis (NASH) and... | |||
TP1111L | Tirzepatide Acetate(2023788-19-2 free base) | Glucagon Receptor | |
Tirzepatide acetate is a dual GIP / GLP-1 receptor agonist. | |||
TP1111 | Tirzepatide | LY-3298176 | Glucagon Receptor |
Tirzepatide (LY-3298176) is a dual agonist of glucose-dependent polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor with neuroprotective activity for the study of diabetes and obesity. | |||
TP1110 | Tirzepatide hydrochloride | LY3298176 hydrochloride | |
Tirzepatide hydrochloride (LY3298176 hydrochloride) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. | |||
T37599 | DA-JC4 | DA-JC4 | |
DA-JC4 is a compound with dual GLP-1/GIP receptor agonist properties. It is recommended for use in researching neurological diseases and investigating insulin signaling pathways[1][2][3]. | |||
T76006 | Tirzepatide TFA | Tirzepatide TFA(2023788-19-2 free base),LY3298176 TFA | |
Tirzepatide TFA (LY3298176 TFA), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is under development for type 2 diabetes treatment [1]. | |||
T36760 | KQMEEEAVRLFIEWLKNGGPSSGAPPPS | ||
KQMEEEAVRLFIEWLKNGGPSSGAPPPS is a Exendin-4 peptide derivative. Exendin-4 is a pure GLP-1 receptor agonist. Exendin-4 peptide derivatives are structurally derived from Exendin-4 and may relates to dual GLP-1/glucagon rec... | |||
T82923 | Bamadutide | SAR425899 | |
Bamadutide (SAR425899) is a potent dual agonist for the glucagon-like peptide-1 receptor and glucagon receptor, which notably enhances β-cell function and decreases the rate of glucose absorption in vivo, thereby improvi... |